Cargando…
Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527742/ https://www.ncbi.nlm.nih.gov/pubmed/28794572 http://dx.doi.org/10.4103/ijd.IJD_97_17 |
_version_ | 1783252982752608256 |
---|---|
author | Kurosaki, Yuko Takamori, Kenji Suga, Yasushi |
author_facet | Kurosaki, Yuko Takamori, Kenji Suga, Yasushi |
author_sort | Kurosaki, Yuko |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5527742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55277422017-08-09 Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents Kurosaki, Yuko Takamori, Kenji Suga, Yasushi Indian J Dermatol Correspondence Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5527742/ /pubmed/28794572 http://dx.doi.org/10.4103/ijd.IJD_97_17 Text en Copyright: © 2017 Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Correspondence Kurosaki, Yuko Takamori, Kenji Suga, Yasushi Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title | Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title_full | Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title_fullStr | Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title_full_unstemmed | Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title_short | Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents |
title_sort | refractory psoriasis vulgaris with itching successfully treated with the anti-interleukin-17a antibody secukinumab: a case of secondary failure of other biologic agents |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527742/ https://www.ncbi.nlm.nih.gov/pubmed/28794572 http://dx.doi.org/10.4103/ijd.IJD_97_17 |
work_keys_str_mv | AT kurosakiyuko refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents AT takamorikenji refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents AT sugayasushi refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents |